These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8390813)
21. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Carlson JR; Thornton SA; DuPont HL; West AH; Mathewson JJ Antimicrob Agents Chemother; 1983 Oct; 24(4):509-13. PubMed ID: 6651278 [TBL] [Abstract][Full Text] [Related]
22. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens. O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257 [TBL] [Abstract][Full Text] [Related]
23. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone. Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500 [TBL] [Abstract][Full Text] [Related]
24. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019 [TBL] [Abstract][Full Text] [Related]
25. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. Fass RJ Antimicrob Agents Chemother; 1993 Oct; 37(10):2080-6. PubMed ID: 8257127 [TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin. Taylor DE; Chang N Antimicrob Agents Chemother; 1991 Sep; 35(9):1917-8. PubMed ID: 1659309 [TBL] [Abstract][Full Text] [Related]
27. [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis]. Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M Kansenshogaku Zasshi; 1994 Nov; 68(11):1390-408. PubMed ID: 7829908 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis. Landínez R; Liñares J; Loza E; Martínez-Beltrán J; Martín R; Baquero F Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):265-7. PubMed ID: 1317801 [TBL] [Abstract][Full Text] [Related]
29. [Study of the sensitivity of enteropathogenic bacteria to nifurzide]. Gavinet AM; Mégraud F Pathol Biol (Paris); 1987 May; 35(5):542-4. PubMed ID: 3302859 [TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of lomefloxacin activity in Colombia. Trujillo H; Mejia GI; Castrillon L; Gomez C Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498 [TBL] [Abstract][Full Text] [Related]
31. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis]. Fukuyama M; Kawakami K; Suda O; Imagawa Y Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800 [TBL] [Abstract][Full Text] [Related]
32. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Malanoski GJ; Eliopoulos GM; Ferraro MJ; Moellering RC Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):131-3. PubMed ID: 8388791 [TBL] [Abstract][Full Text] [Related]
33. In vitro activity of azithromycin against clinical isolates of Legionella species. Edelstein PH; Edelstein MA Antimicrob Agents Chemother; 1991 Jan; 35(1):180-1. PubMed ID: 1849708 [TBL] [Abstract][Full Text] [Related]
34. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis]. Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline. Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626 [TBL] [Abstract][Full Text] [Related]
36. Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2. Spangler SK; Appelbaum PC J Clin Microbiol; 1993 Feb; 31(2):460-2. PubMed ID: 8381817 [TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of RU-66647, a new ketolide. Jones RN; Biedenbach DJ Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone. Clement JJ; Tanaka SK; Alder J; Vojtko C; Beyer J; Hensey D; Ramer N; McDaniel D; Chu DT Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740 [TBL] [Abstract][Full Text] [Related]
39. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Brown BA; Wallace RJ; Onyi GO; De Rosas V; Wallace RJ Antimicrob Agents Chemother; 1992 Jan; 36(1):180-4. PubMed ID: 1317144 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. Pajukanta R; Asikainen S; Saarela M; Alaluusua S; Jousimies-Somer H Antimicrob Agents Chemother; 1992 Jun; 36(6):1241-3. PubMed ID: 1329617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]